The Saudi Arabia diabetes devices market size accounted for USD 199.65 million in 2025 and is predicted to touch around USD 441.11 million by 2035, growing at a CAGR of 8.25% from 2026 to 2035. Rising prevalence of diabetes and the need of continues monitoring are driving the market.

Saudi Arabia Diabetes Devices Market Statical Scope

In the blood glucose monitoring devices market in Saudi Arabia, one of the primary drivers is the growing incidence of diabetes, particularly type 2 diabetes. The country has one of the highest diabetes rates in the Middle East, affecting a substantial portion of the population. Government initiatives aimed at raising diabetes awareness and encouraging healthcare practitioners to engage in screening and early interventions, including lifestyle changes, are expected to contribute to overall market growth.

In recent years, Saudi Arabia has made significant advances in digital transformation, implementing advanced technologies across various sectors and launching initiatives like the Ministry of Health (MOH) Vision for E-Health . This demonstrates the nation's commitment to becoming technologically advanced. In diabetes care, the utilization of continuous glucose monitors (CGMs) and insulin pump , in conjunction with smartphone apps and cloud-based platforms, can significantly enhance the quality, accessibility, efficiency, and cost-effectiveness of diabetes management.'

Saudi Arabia Diabetes Devices Market Share, By Type, 2025, (%)

• Insulin delivery devices- This segment dominates due to the rising diabetic population's need for continuous insulin administration, and holds 55% share, due to rising adoption of advanced delivery systems like insulin pens and pumps.
• Blood glucose monitoring devices- Blood glucose monitoring devices are widely used for routine diabetes management, holding around 45% share, driven by the conveniences offered by them.

Saudi Arabia Diabetes Devices Market Share, By Distribution Channel, 2025, (%)

• Hospital pharmacies- This segment dominates because of high patient reliance on hospital-based prescriptions, with around 55% share, driven by good availability of diabetes devices and trust in clinical settings.
• Retail pharmacies- This segment serves as a convenient access point for patients, capturing about 20% share, due to widespread local presence.
• Diabetes clinics/centers- This segment is growing as specialized diabetes care centers offer targeted treatment, accounting for 10% share, driven by growing outpatient volume.
• Online pharmacies- This segment is experiencing demand due to an increase in e-commerce , growing digital adoption, and convenience with home delivery, holding 8% share.

Saudi Arabia Diabetes Devices Market Share, By End Use, 2025, (%)

• Homecare- This segment dominates the market as patients increasingly shifting toward self-monitoring and at-home management, holding about 44% share, also driven by user-friendly devices.
• Hospitals- This segment holds a significant share of about 41% because to access to advanced treatment and monitoring along with high patient flow.
• Diagnostic centers- This segment is driven by demand for point-of-care diagnostics and holds 15% share.

Top Companies in the Saudi Arabia Diabetes Devices Market

• Medtronic plc
• Abbott Laboratories
• F. Hoffmann-La Roche Ltd
• Bayer AG
• Lifescan, Inc.
• B Braun Melsungen AG
• Dexcom Inc.
• Insulet Corporation
• Sanofi
• Novo Nordisk A/S
• BD

Segments Covered in the Report

By Type

• Blood Glucose Monitoring Devices
  • Self-monitoring Devices
  • Blood Glucose Meters
  • Testing Strips
  • Lancets
  • Continuous Glucose Monitoring Devices
  • Sensors
  • Transmitters
  • Receiver
• Insulin Delivery Devices
  • Insulin Pumps
  • Insulin Pens
  • Insulin Syringes
  • Insulin Jet Injectors

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Diabetes Clinics/Centers
• Online Pharmacies
• Others

By End-use

• Hospitals
• Homecare
• Diagnostic Centers